Search Results

There are 3255 results for: content related to: The pathophysiology of faecal spotting in obese subjects during treatment with orlistat

  1. Inhibition of Fatty Acid Synthase by Orlistat Accelerates Gastric Tumor Cell Apoptosis in Culture and Increases Survival Rates in Gastric Tumor Bearing Mice In Vivo

    Lipids

    Volume 44, Issue 6, June 2009, Pages: 489–498, Shawn Dowling, James Cox and Richard J. Cenedella

    Version of Record online : 21 APR 2009, DOI: 10.1007/s11745-009-3298-2

  2. Long-term pharmacotherapy for obesity and overweight

    Intervention Review

    The Cochrane Library

    Raj S Padwal, Diana Rucker, Stephanie K Li, Cintia Curioni and David CW Lau

    Published Online : 20 OCT 2003, DOI: 10.1002/14651858.CD004094.pub2

  3. Anti-Tumorigenic Potential of a Novel Orlistat-AICAR Combination in Prostate Cancer Cells

    Journal of Cellular Biochemistry

    Volume 118, Issue 11, November 2017, Pages: 3834–3845, Clayton Wright, Anand Krishnan V. Iyer, Vivek Kaushik and Neelam Azad

    Version of Record online : 23 MAY 2017, DOI: 10.1002/jcb.26033

  4. A systematic review of the clinical effectiveness of orlistat used for the management of obesity

    Obesity Reviews

    Volume 5, Issue 1, February 2004, Pages: 51–68, S. O'Meara, R. Riemsma, L. Shirran, L. Mather and G. Ter Riet

    Version of Record online : 16 JAN 2004, DOI: 10.1111/j.1467-789X.2004.00125.x

  5. You have free access to this content
    Weight Loss, Weight Maintenance, and Improved Cardiovascular Risk Factors after 2 Years Treatment with Orlistat for Obesity

    Obesity Research

    Volume 8, Issue 1, January 2000, Pages: 49–61, Professor Stephan Rössner, Lars Sjöström, Rudolf Noack, A. Edo Meinders, Giorgio Noseda and on behalf of the European Orlistat Obesity Study

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2000.8

  6. Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 4, April 2009, Pages: 361–371, S. Jacob, M. Rabbia, M. K. Meier and J. Hauptman

    Version of Record online : 22 JAN 2009, DOI: 10.1111/j.1463-1326.2008.00970.x

  7. You have free access to this content
    Long-term effects of weight-reducing drugs in people with hypertension

    Intervention Review

    The Cochrane Library

    Andrea Siebenhofer, Klaus Jeitler, Karl Horvath, Andrea Berghold, Nicole Posch, Jutta Meschik and Thomas Semlitsch

    Published Online : 2 MAR 2016, DOI: 10.1002/14651858.CD007654.pub4

  8. You have free access to this content
    Drug interventions for the treatment of obesity in children and adolescents

    Intervention Review

    The Cochrane Library

    Emma Mead, Greg Atkinson, Bernd Richter, Maria-Inti Metzendorf, Louise Baur, Nicholas Finer, Eva Corpeleijn, Claire O'Malley and Louisa J Ells

    Published Online : 29 NOV 2016, DOI: 10.1002/14651858.CD012436

  9. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Susan L Norris, Xuanping Zhang, Alison Avenell, Edward Gregg, Christopher H Schmid and Joseph Lau

    Published Online : 24 JAN 2005, DOI: 10.1002/14651858.CD004096.pub2

  10. Effects of orlistat on obesity-related diseases – a six-month randomized trial

    Diabetes, Obesity and Metabolism

    Volume 6, Issue 5, September 2004, Pages: 375–383, B. Guy-Grand, P. Drouin, E. Eschwège, H. Gin, J-M. Joubert and P. Valensi

    Version of Record online : 2 AUG 2004, DOI: 10.1111/j.1462-8902.2004.00359.x

  11. Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients

    Diabetes, Obesity and Metabolism

    Volume 5, Issue 3, May 2003, Pages: 180–188, A. Halpern, M. C. Mancini, H. Suplicy, M. T. Zanella, G. Repetto, J. Gross, M. Jadzinsky, J. Barranco, P. Aschner, L. Ramirez and A. G. Matos

    Version of Record online : 4 APR 2003, DOI: 10.1046/j.1463-1326.2003.00262.x

  12. You have free access to this content
    NPY5R Antagonism Does Not Augment the Weight Loss Efficacy of Orlistat or Sibutramine

    Obesity

    Volume 15, Issue 8, August 2007, Pages: 2027–2042, Ngozi Erondu, Carol Addy, Kaifeng Lu, Madhuja Mallick, Bret Musser, Ira Gantz, Joseph Proietto, Arne Astrup, Søren Toubro, Aila M. Rissannen, Serena Tonstad, William G. Haynes, Keith M. Gottesdiener, Keith D. Kaufman, John M. Amatruda and Steven B. Heymsfield

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2007.242

  13. You have free access to this content
    Orlistat 60 mg Reduces Visceral Adipose Tissue: A 24-Week Randomized, Placebo-Controlled, Multicenter Trial

    Obesity

    Volume 19, Issue 9, September 2011, Pages: 1796–1803, Steven R. Smith, Kaj S. Stenlof, Frank L. Greenway, John McHutchison, Susan M. Schwartz, Vidhu B. Dev, Evan S. Berk and Roxanne Kapikian

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2011.143

  14. You have free access to this content
    Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model

    International Journal of Cancer

    Volume 123, Issue 11, 1 December 2008, Pages: 2557–2565, Marco A. Carvalho, Karina G. Zecchin, Fabiana Seguin, Débora C. Bastos, Michelle Agostini, Ana Lúcia C.A. Rangel, Sílvio S. Veiga, Helena F. Raposo, Helena C.F. Oliveira, Massimo Loda, Ricardo D. Coletta and Edgard Graner

    Version of Record online : 3 SEP 2008, DOI: 10.1002/ijc.23835

  15. You have free access to this content
    Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: systematic review and meta-analysis

    International Journal of Clinical Practice

    Volume 70, Issue 6, June 2016, Pages: 450–461, S. K. Graff, F. M. Mario, P. Ziegelmann and P. M. Spritzer

    Version of Record online : 26 MAY 2016, DOI: 10.1111/ijcp.12787

  16. The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial

    Diabetes, Obesity and Metabolism

    Volume 4, Issue 6, November 2002, Pages: 415–423, M. Hanefeld and G. Sachse

    Version of Record online : 30 OCT 2002, DOI: 10.1046/j.1463-1326.2002.00237.x

  17. Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients

    Fundamental & Clinical Pharmacology

    Volume 25, Issue 5, October 2011, Pages: 642–651, Giuseppe Derosa, Pamela Maffioli, Ilaria Ferrari, Angela D’Angelo, Elena Fogari, Ilaria Palumbo, Sabrina Randazzo and Arrigo F.G. Cicero

    Version of Record online : 16 NOV 2010, DOI: 10.1111/j.1472-8206.2010.00888.x

  18. You have free access to this content
    Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol

    The Journal of Physiology

    Volume 577, Issue 1, November 2006, Pages: 263–280, Bela Szabo, Michal J. Urbanski, Tiziana Bisogno, Vincenzo Di Marzo, Aitziber Mendiguren, Wolfram U. Baer and Ilka Freiman

    Version of Record online : 8 NOV 2006, DOI: 10.1113/jphysiol.2006.119362

  19. Orlistat for the treatment of obesity: rapid review and cost-effectiveness model

    Obesity Reviews

    Volume 1, Issue 2, October 2000, Pages: 121–126, D. R. Foxcroft and R. Milne

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1467-789x.2000.00011.x

  20. Treatment of obesity: an update on anti-obesity medications

    Obesity Reviews

    Volume 4, Issue 1, February 2003, Pages: 25–42, A. Halpern and M. C. Mancini

    Version of Record online : 7 FEB 2003, DOI: 10.1046/j.1467-789X.2003.00083.x